Advanced

OpenSpecimen moves disease study forward at the biobank

Posted by bob on · Post a comment
Opensource.com; By Srikanth Adiga 		Mail this story
Print this story

Access to high-quality human biospecimens such as blood, saliva, plasma, DNA, and RNA is integral to developing a better understanding of diseases and advancing molecular technologies, clinical trial research, personalized medicine research, and clinical practice.

Full Story

  Nav
» Read more about: Story Type: Editorial; Groups: Community, Standards

» Get new stories by e-mail: nightly or as they are published

« Return to the newswire homepage

Comments

No comments yet. Be the first.

Post a comment

A free account is needed to post. Write your comment here first: your text is kept in this browser while you sign up or log in, and is waiting for you when you come back.

Your message:
|||||
10
Markdown: **bold**, *italic*, [text](https://link), - lists, > quotes, $x^2$ for math. Formatting help

Sign up and post (it is free)  or  Log in and post